Mumbai, June 24 -- Glenmark Pharmaceuticals (Glenmark) launched TEVIMBRA(R) (tislelizumab) in India following the approval by Central Drugs Standard Control Organization (CDSCO).

Published by HT Digital Content Services with permission from Capital Market....